Systemic adjuvant therapy with BCG versus BCG + 5FU in colorectal cancer Dukes' Class C: updated critical analysis.
D000368:Aged; D001500:BCG Vaccine / Q000627:therapeutic use*; D002272:Carcinoembryonic Antigen / Q000032:analysis; D002986:Clinical Trials as Topic; D003110:Colonic Neoplasms / Q000032:analysis / Q000628:therapy*; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D012004:Rectal Neoplasms / Q000032:analysis / Q000628:therapy*; D012044:Regression Analysis; D012075:Remission, Spontaneous; D013997:Time Factors
D001500:BCG Vaccine; D002272:Carcinoembryonic Antigen; D005472:Fluorouracil